Duke Cancer Institute

Duke Cancer Institute. The Duke Cancer Institute is a comprehensive cancer center designated by the National Cancer Institute and part of the Duke University Health System. It integrates the research, clinical care, and education missions of the Duke University School of Medicine to advance the understanding and treatment of cancer. The institute brings together hundreds of faculty members across numerous disciplines to conduct translational research and provide multidisciplinary patient care.

History

The origins trace back to 1972 with the founding of the Duke Comprehensive Cancer Center, one of the first eight such centers recognized by the National Cancer Institute. This early designation established a foundation for integrated cancer research and treatment. In 2010, the institution was reorganized and renamed to its current form to better unify efforts across the university and health system. This transformation was part of a broader strategic vision to accelerate the translation of scientific discoveries into clinical applications, a process championed by leaders like former Duke University president Richard H. Brodhead and health system executives. The institute's growth has been marked by significant philanthropic support, including a landmark gift from the Leonard M. and Harry B. Helmsley Charitable Trust.

Research programs

Research is organized into multidisciplinary programs that bridge basic science and clinical investigation. These include focused efforts in breast cancer, gastrointestinal cancer, brain tumors, hematologic malignancies, and thoracic oncology, among others. Scientists and clinicians collaborate within shared resource cores, such as those for genomics, biostatistics, and bioinformatics, supported by grants from the National Institutes of Health. Pioneering work at the institute has contributed to advances in immunotherapy, precision medicine, and radiation therapy. Notable research outputs often involve partnerships with entities like the American Cancer Society and industry leaders, and findings are regularly published in journals such as The New England Journal of Medicine and Nature.

Clinical care

Clinical services are delivered through a network of locations across North Carolina, with the main facility situated on the campus of Duke University Hospital in Durham, North Carolina. The institute operates more than a dozen multidisciplinary clinics where teams of specialists—including medical oncologists, surgical oncologists from the Department of Surgery, and radiation oncologists—develop individualized treatment plans. It offers access to a wide portfolio of clinical trials, ranging from early-phase studies to large national trials coordinated by groups like the ECOG-ACRIN Cancer Research Group. Supportive care services, including palliative care and cancer survivorship programs, are integral components of the patient care model.

Education and training

The institute is deeply involved in educating the next generation of cancer specialists and scientists. It provides extensive training through fellowship programs in medical oncology, hematology, and radiation oncology, accredited by the Accreditation Council for Graduate Medical Education. Postdoctoral researchers and clinical fellows train under the mentorship of senior faculty, many of whom are members of prestigious societies like the American Association for Cancer Research. Educational outreach extends to the community through public seminars and partnerships with organizations such as the National Breast Cancer Foundation. Continuing medical education for practicing physicians is also a key activity, often in collaboration with the American Society of Clinical Oncology.

Leadership and organization

The institute is led by a director who oversees its strategic direction and operations, reporting to the leadership of the Duke University School of Medicine and the Duke University Health System. It functions as a matrix organization, drawing faculty from various academic departments including Medicine, Pathology, Pharmacology, and Radiation Oncology. Governance involves several advisory boards, including a scientific oversight committee and a community-focused board of advocates. The institute maintains formal research partnerships with other National Cancer Institute-designated cancer centers and is a contributing member to national consortia like the National Comprehensive Cancer Network.

Category:Cancer centers in the United States Category:Duke University Category:Medical and health organizations based in North Carolina Category:Organizations established in 1972